XML 28 R18.htm IDEA: XBRL DOCUMENT v3.22.2.2
Earnings Per Share
9 Months Ended
Sep. 30, 2022
Earnings Per Share  
Earnings Per Share

Note 10 - Earnings Per Share

Basic earnings per share is computed by dividing net loss by the weighted-average number of shares of common stock outstanding during each period. Diluted earnings per share is based on the treasury stock method and computed by dividing net loss available to common stockholders by the diluted weighted-average shares of common stock outstanding during each period. The Company’s potentially dilutive shares include stock options, warrants for the shares of common stock and restricted stock awards. The potentially dilutive shares are considered to be common stock equivalents and are only included in the calculation of diluted net loss per share when the effect is dilutive. The investor warrants are treated as equity in the calculation of diluted earnings per share in both the computation of the numerator and denominator, if

dilutive. The following table sets forth the calculations of basic and diluted earnings per share for the three and nine months ended September 30, 2022 and 2021:

Three Months Ended September 30, 

Nine Months Ended September 30, 

    

2022

    

2021

    

2022

    

2021

Net loss

$

(6,411,000)

$

(3,628,000)

$

(14,117,000)

$

(10,851,000)

Less: decrease in fair value of investor warrants

(1,167,000)

(222,000)

(5,384,000)

(489,000)

Net loss available to common stockholders

$

(7,578,000)

$

(3,850,000)

$

(19,501,000)

$

(11,340,000)

Basic weighted-average common shares outstanding

15,072,392

13,361,292

15,072,307

13,156,469

Add: dilutive effect of equity instruments

76,251

81,935

Diluted weighted-average shares outstanding

15,072,392

13,437,543

15,072,307

13,238,404

Earnings per share – basic

$

(0.43)

$

(0.27)

$

(0.94)

$

(0.82)

Earnings per share – diluted

$

(0.50)

$

(0.29)

$

(1.29)

$

(0.86)

The potentially dilutive shares of common stock that have been excluded from the calculation of net loss per share because of their anti-dilutive effect are as follows:

Three Months Ended September 30, 

Nine Months Ended September 30, 

2022

    

2021

    

2022

    

2021

Warrants to purchase shares of common stock

1,065,137

165,324

1,065,137

159,639

Outstanding stock options

364,125

378,466

364,125

378,466

Restricted stock awards

13,400

13,400

Total potentially dilutive shares of common stock

1,442,662

543,790

1,442,662

538,105